Navigation Links
DoctorDirectory to Co-market VoSpire ER(R) with DAVA Pharmaceuticals, Inc.
Date:7/29/2008

ASHEVILLE, N.C., July 29 /PRNewswire/ -- DoctorDirectory.com, Inc. announced that it is partnering with DAVA Pharmaceuticals, Inc. to co-market VoSpire ER(R) (Albuterol Sulfate) Extended-Release Tablets through its IncreaseRx(R) virtual marketing solution. IncreaseRx utilizes web-based educational and promotional tactics to reach tens of thousands of interested prescribers with targeted sales and marketing messages. Essentially, IncreaseRx performs as a virtual contract sales organization providing e-sampling and online educational tools. "Our team is looking forward to promoting VoSpire ER(R) with DAVA. Albuterol sulfate remains a standard of long-lasting oral therapy for patients," said Jay Grobowsky, CEO for DoctorDirectory.

VoSpire ER(R) is indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.

"We at DAVA felt that the DoctorDirectory team and the IncreaseRx solution were an excellent fit for the continued promotion of VoSpire ER(R). The strength of IncreaseRx is in its ability to reach far more prescribers than we could have by utilizing a traditional sales force model. The value-based relationship that DoctorDirectory has with its physicians gives our brand a particularly attractive solution," said Liad Spiro, Senior Director, Commercialization and Marketing for DAVA.

DoctorDirectory is a marketing solutions company that specializes in providing brand teams and their agencies web-based access to Healthcare Professionals. IncreaseRx is a whitespace strategy designed to reach under-performing or inaccessible physician segments and generate incremental revenue from unrealized potential. It utilizes a suite of traditional and web-based tactics to generate incremental revenue for any pharma brand regardless of product life cycle.

For more information about DoctorDirectory or IncreaseRx, contact Jay Grobowsky at 828-255-0252 or by email at jay.grobowsky@doctordirectory.com.

DAVA Pharmaceuticals, Inc. is a global pharmaceutical company committed to providing cost-effective pharmaceutical products to the healthcare market by integrating expertise in product development, manufacturing and marketing with global strategic alliances to deliver medicines from the source.

For more information about DAVA Pharmaceuticals, Inc., contact Liad Spiro at 201-947-7442 or by email at LSpiro@davapharma.com.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE DoctorDirectory.com, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. XCPT(TM) Patient Engagement and Communication Software and DentalXP.com, a Leading Provider of Online Dental Education and Content, Sign a Co-Marketing Agreement
2. Energizer Joins Roster of Susan G. Komen Race for the Cure(R) National Sponsors; Energizer(R) ReTreat Pampers Cancer Survivors With Traveling Mini-Spa
3. Infor-Med, Inc. Announces New Praxis EMR Version 4 with The Praxis Knowledge Exchanger(R)
4. Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available
5. FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
6. Nano Pet Products, LLC Named Exclusive Worldwide Licensee by Schoeller(R) Technologies AG for Pet Products to Develop the Most Technologically Advanced Pet Brands on the Market Today
7. Pioneer(R) Surgical Technology, Inc. Continues to Prove Science Behind PEEK-on-PEEK(TM) Technology for Motion Preservation Devices
8. Quaker(R) Life(R) Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen
9. Kinetic Technologies, Makers of Conquer(R), Introduces New Website
10. CAS New SciFinder(R) Enhances the Research Experience Via the Web
11. AGA Medical Corporation Receives CE Mark Approval for the AMPLATZER(R) Vascular Plug III
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... A ... revolutionize the emergency ambulance transport experience for the millions of people who require ... has disrupted the taxi industry through the use of technology. Now, SmartEMS has ...
(Date:6/26/2016)... ... , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center ... Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This annual ... the world’s leading providers of cereal and other breakfast foods. Its residents often refer ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
Breaking Medicine Technology: